{"public_metrics": {"retweet_count": 539, "reply_count": 185, "like_count": 754, "quote_count": 293}, "lang": "en", "possibly_sensitive": false, "source": "SocialFlow", "entities": {"annotations": [{"start": 125, "end": 139, "probability": 0.5346, "type": "Organization", "normalized_text": "Gilead Sciences"}], "urls": [{"start": 257, "end": 280, "url": "https://t.co/DY2MPZ4Zhg", "expanded_url": "https://nyti.ms/38cdKjT", "display_url": "nyti.ms/38cdKjT"}]}, "text": "After weeks of donating the antiviral drug remdesivir to hospitals with severely ill coronavirus patients, the drug\u2019s maker, Gilead Sciences, announced that it has settled on a price: $390 per vial, which works out to be roughly $2,340 per treatment course https://t.co/DY2MPZ4Zhg", "reply_settings": "everyone", "conversation_id": "1277626387898216449", "context_annotations": [{"domain": {"id": "123", "name": "Ongoing News Story", "description": "Ongoing News Stories like 'Brexit'"}, "entity": {"id": "1220701888179359745", "name": "COVID-19"}}, {"domain": {"id": "47", "name": "Brand", "description": "Brands and Companies"}, "entity": {"id": "10040666972", "name": "The New York Times"}}, {"domain": {"id": "29", "name": "Events [Entity Service]", "description": "Entity Service related Events domain"}, "entity": {"id": "1263485418844024832", "name": "COVID-19: Global updates ", "description": "The latest news and analysis on the coronavirus pandemic from around the world."}}], "created_at": "2020-06-29T15:34:02.000Z", "id": "1277626387898216449", "author_id": "807095"}